DENYES NANCY
SEC CIK 1640869 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATYR | aTYR PHARMA INC | GC | 33.1K | $9,300 | $4,494 | 7 | 2023-02-03 | 2026-02-04 |
Most active insiders at ATYR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SCHIMMEL PAUL | Dir | $962.3K | — |
| 2 | Shukla Sanjay | Pres, CEO, Dir | — | $3,670 |
| 3 | Broadfoot Jill Marie | CFO | — | $1,527 |
| 4 | DENYES NANCY | GC | — | $1,096 |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-04 | 2026-02-03 | ATYR | aTYR PHARMA INC | DENYES NANCY | GC | M - OptEx | — | +2,687 | 34.2K | +9% | — |
| D | 2026-02-04 | 2026-02-04 | ATYR | aTYR PHARMA INC | DENYES NANCY | GC | S - Sale+OE | $0.98 | -1,118 | 33.1K | -3% | -$1,096 |
| D | 2025-02-04 | 2025-02-03 | ATYR | aTYR PHARMA INC | DENYES NANCY | GC | M - OptEx | — | +2,687 | 27.5K | +11% | — |
| D | 2025-02-04 | 2025-02-04 | ATYR | aTYR PHARMA INC | DENYES NANCY | GC | S - Sale+OE | $3.78 | -899 | 26.6K | -3% | -$3,398 |
| 2024-06-06 | 2024-06-05 | ATYR | aTYR PHARMA INC | DENYES NANCY | GC | P - Purchase | $1.86 | +5,000 | 22.3K | +29% | +$9,300 | |
| D | 2024-02-06 | 2024-02-05 | ATYR | aTYR PHARMA INC | DENYES NANCY | GC | M - OptEx | — | +2,688 | 14.8K | +22% | — |
| D | 2023-02-06 | 2023-02-03 | ATYR | aTYR PHARMA INC | DENYES NANCY | GC | M - OptEx | — | +2,688 | 7,079 | +61% | — |
Purchase Sale Sale after option exercise All abbreviations